LoDAC Clinical Trials

1 actively recruiting trial

Also known as: Low Dose Cytarabine

Pipeline

Phase 3: 1

Top Sponsors

Sunshine Lake Pharma Co., Ltd.1

Indications

Leukemia Acute Myeloid - AML1
Cancer1

Other1 trial

HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.